What is the appropriate management for a patient with pneumonia and a C‑reactive protein level of 5.9 mg/dL?

Management of Pneumonia with CRP 5.9 mg/dL

With a CRP of 59 mg/L (5.9 mg/dL), this patient has confirmed pneumonia and requires immediate antibiotic treatment along with risk stratification using CRB65 scoring to determine the appropriate care setting. 1

Interpretation of the CRP Level

Your patient's CRP of 59 mg/L falls in the intermediate range that strongly supports the diagnosis of pneumonia:

• CRP >20 mg/L with clinical symptoms confirms bacterial pneumonia and warrants antibiotic therapy 1, 2
• This level (59 mg/L) is well above the 20 mg/L threshold but below 100 mg/L, placing it in the range where pneumonia is likely but not severe 1
• Research shows CRP >48 mg/L has 91% sensitivity and 93% specificity for pneumonia diagnosis 3
• The 2019 CHEST guidelines note that CRP ≥30 mg/L combined with suggestive symptoms significantly increases pneumonia likelihood 2

Immediate Management Algorithm

Step 1: Risk Stratification with CRB65

Calculate the CRB65 score immediately (1 point each for):

• Confusion (new disorientation in person, place, or time)
• Respiratory rate ≥30 breaths/min
• Blood pressure (systolic <90 mmHg or diastolic ≤60 mmHg)
• Age 65 or older

Risk categories:

• Score 0: Low risk (<1% mortality) → consider home-based care
• Score 1-2: Intermediate risk (1-10% mortality) → clinical judgment needed
• Score 3-4: High risk (>10% mortality) → consider hospital assessment 1

Step 2: Antibiotic Initiation

Start empirical antibiotics immediately - do not delay for further testing 1, 2:

• Combination β-lactam plus macrolide is the standard empirical regimen for hospitalized patients 4
• The CRP level of 59 mg/L is in the range (20-100 mg/L) where NICE guidelines support antibiotic prescription with clinical judgment 1

Step 3: Determine Care Setting

• CRB65 score 0: Home-based care with oral antibiotics
• CRB65 score 1-2: Shared decision-making about hospital vs. home care (consider virtual ward or community intervention team)
• CRB65 score ≥2: Consider hospital assessment 1

Prognostic Considerations

The CRP level provides important prognostic information:

• Higher CRP levels (>110 mg/L) are associated with more severe disease, particularly pneumococcal and Legionella pneumonia 5
• Your patient's CRP of 59 mg/L suggests moderate severity
• Monitor CRP decline: Failure of CRP to decrease by >50% by day 4 is associated with higher risk of complications, need for ventilatory support, and mortality 4
• In older patients (>60 years), higher peak CRP correlates with worse hospital prognosis 6

Key Pitfalls to Avoid

1. Do not withhold antibiotics based on this CRP level - 59 mg/L clearly exceeds the 20 mg/L threshold for treatment 1

2. Do not rely on CRP alone - always combine with clinical assessment and CRB65 scoring 1

3. Do not order routine microbiological testing unless results would change therapy 2

4. Do not prescribe prolonged antibiotic courses - short courses are equally effective unless complications develop 4

5. Reassess clinically within 48-72 hours and check repeat CRP by day 4 to ensure appropriate response 4

Monitoring Plan

• Repeat CRP on day 4 of treatment
• Expect >50% decline from baseline if responding appropriately
• If CRP fails to decline adequately, consider complications (empyema, treatment failure, alternative diagnosis) 4
• Clinical reassessment takes priority over biomarker trends 1